Subscribe Now
 Already a subscriber? Log-in!
The monthly Laboratory Industry Report delivers expert perspective and trusted guidance on critical regulatory updates, operational and financial trends, plus trusted forecasts on the future of the diagnostic laboratory industry.
As a member of the Laboratory Industry Report community, you’ll take advantage of over 30 years of experience including:
- Expert strategies and advice on healthcare integration, capitation, lab technology and more
- Analysis of regulatory impact and relevant details on proposed legislation
- Comparative data on diagnostic lab test pricing and volumes
- Benchmarks to gauge your lab operations versus the diagnostic lab market at large
- Details on publicly-held labs, including executive earnings and performance
- Updates on industry mergers, acquisitions and alliances and large labs’ business activities
Laboratory Industry Report gives you direct access to industry experts to keep you current and informed on the latest issues affecting diagnostic laboratories across practice settings – hospital, commercial, group practice sites and network systems.
Clients find their membership to “LIR” to be much more than a news source; it’s where they to turn for business intelligence and exclusive insight on what's happening to key companies, how Wall Street views the industry, or the latest on mergers, buyouts, consolidations and alliances.
For over 30 years Laboratory Industry Report is a trusted resource for everyone with a vital stake in today's competitive diagnostic lab marketplace – from owners, directors, pathologists, CEOs, COOs, and CFOs to general managers, administrators, lab managers, and sales/marketing professionals.
As always Laboratory Industry Report, guarantees the accuracy, objectivity, and authority of its actionable
intelligence.
Gain a competitive edge for your diagnostic lab!
|
|
|
 |
 | LIR September 2010 Full PDF Issue |
| TOP OF THE NEWS
Gap widens in G-2’s second-
quarter benchmarking analysis
BUSINESS/FINANCIAL
Profile: Summit Pathology—
Merging two groups: when
the sum is greater than the parts
Medicare Part B lab spending
up 11% in 2009 Aetna files lawsuit against
LabCorp
PAML forms new joint venture
with Providence Health
Sequenom adding genetics lab
in La Jolla for T21 testing Lab index loses some ground,
down 3% in August INSIDE THE LAB INDUSTRY
Lab industry expected to grow
8% in 2010
EYE ON IMAGING
Job market for radiologic
techs tightening
INDUSTRY BUZZ
Roche buys digital pathology firm
Full Article |
| Gap Widens in G-2’s Second-Quarter Benchmarking Analysis; Most Labs Show Gains in Revenue Per Employee |
| The gap widened even more in Washington G-2 Reports’ second-quarter benchmarking analysis, with San Diego-based Genoptix and Salt Lake City-based Myriad Genetics continuing to lead in two key benchmarking measures—revenue per full-time employee (FTE) and pretax income per FTE (see chart, on pg. 2).
Full Article |
| Lab Industry Still Growing Despite Down Economy |
| The overall clinical laboratory is expected to grow about 8 percent in 2010, with growth driven by esoteric testing and anatomic pathology, according to Washington G-2 Reports’ Laboratory Industry Analysis 2010.
Full Article |
| Profile: Summit Pathology Merging Two Groups: When the Sum Is Greater Than the Parts |
| When Greeley Pathologists and Colorado Pathology Associates merged in 2007, the two groups had a number of hurdles to overcome. Although each served hospitals that were part of the same health system and shared a laboratory information system (LIS) owned by the health system, the groups actually had an adversarial relationship, explained Michael Walts, M.D., who discussed the merger during Washington G-2 Reports’ Laboratory Outreach Conference, held June 2-4, 2010, in Baltimore.
Full Article |
| Lab Industry Expected to Grow 8% in 2010 |
| The U.S. clinical laboratory services market continues to grow at a steady rate, despite the poor economy in late 2008 and 2009. Data compiled by Washington G-2 Reports indicate that the lab market grew about 9.3 percent in 2009 to about $60.2 billion. The overall clinical laboratory market will grow approximately 8 percent in 2010 to reach $65 billion, with esoteric testing and anatomic pathology expected to be the fastest-growing segments, according to the Washington G-2 Reports’ Laboratory Industry Analysis 2010.
Full Article |
| Medicare Part B Lab Spending Up 11% in 2009 |
| Medicare Part B spending on clinical laboratory services continues to increase, with 2009 spending totaling $8.049 billion, an increase of 11 percent over the 2008 total, according to the latest data from the Centers for Medicare and Medicaid Services (CMS) 2010 Medicare Trustees Report.
Full Article |
| Sequenom Adding Genetics Lab in La Jolla for T21 Testing |
| San Diego-based molecular diagnostics company Sequenom plans to open a genetic testing laboratory in La Jolla, Calif., later this year, just in time to start processing samples from a new clinical trial of the company’s experimental test for Down syndrome in unborn babies.
Full Article |
| PAML Forms Joint Venture With Providence Health |
| Spokane-based Pathology Associates Medical Laboratories (PAML) and Providence Health & Services, based in California, have entered into an agreement to create a new clinical laboratory services company serving the San Fernando and neighboring communities.
Full Article |
| Aetna Files Lawsuit Against LabCorp |
| Health insurer Aetna has filed a lawsuit against Laboratory Corporation of America alleging unfair competition, misrepresentation, interference, breach of contract, and violation of trade secret laws. LabCorp announced the lawsuit Aug. 26 in a Form 8K filing with the Securities and Exchange Commission.
Full Article |
| Eye On Imaging: Job Market for Radiologic Techs Tightening |
| The vacancy rate for radiographers has continued to decline in recent years and is now at 2.1 percent, according to a staffing survey recently conducted by the American Society of Radiologic Technologists (ASRT).
Full Article |
| Lab Index Loses Some Ground, Down 3% in August |
| The G-2 Reports’ Laboratory Stock Index gave up some of July’s gains in August, dropping 3 percent in the four weeks ended Aug. 27, 2010. For the year, the index is down 7 percent.
Full Article |
| Roche Buys Digital Pathology Firm |
| Swiss pharmaceutical giant Roche Holding AG is making its move into digital pathology with the purchase of BioImagene Inc., a privately held company based in Sunnyvale, Calif. Roche announced recently that it had signed an agreement under which Ventana Medical Systems, a member of the Roche Group, would pay $100 million for the company, which creates high-resolution, whole-slide digital images from glass microscope slides.
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
